Scott D. Kuduk,Nigel Liverton,Yunfu Luo,Jason W. Skudlarek
申请号：
US15534200
公开号：
US10150751B2
申请日:
2015.12.14
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention is directed to pyrrolidine compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.
